Toledo Water Back On After Toxic Scare

Citizens of Ohio’s fourth-largest city can drink from the tap again, but the root causes of the Lake Erie algal blooms that shut off the flow for two days remain.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

This satellite image shows the algal bloom that occured in Lake Erie in 2011.NASA EARTH OBSERVATORYAfter a parched weekend for more than 400,000 people in and around Toledo, Ohio, safe drinking water is again flowing from their taps, according to city officials. The two-day drinking water ban that started on Saturday (August 2) was prompted by high levels of microcystin—a toxin that can sicken people and kill pets—in Lake Erie, from which water is extracted and processed for municipal supplies. A toxic peptide, microcystin is produced by cyanobacteria, which tend to bloom in the shallow lake during summer months, thanks to phosphorus runoff from farms, fertilized lawns, cattle feedlots, and leaking septic systems.

“Our water is safe,” Toledo Mayor D. Michael Collins told reporters on Monday (August 4) before drinking a glass of tap water at a press conference to announce the lifting of the ban.

Officials still cautioned residents to cut back on non-essential water use, and urged home and business owners to flush their lines to clear any residual toxins in the lines.

Although algal blooms occur in Lake Erie every summer, they became particularly dangerous this year. “Weather conditions made it such that bloom was going right into the water intakes,” Jeffrey Reutter, head of the Ohio Sea Grant research lab, told the Associated Press. This was compounded by the fact that phosphorus levels in the lake have been climbing since the mid-1990s. “We’re right ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies